Zydus Lifesciences Share Price

ABOUT Zydus Lifesciences

• Industry Biotechnology & Drugs
• ISIN INE010B01027
• BSE Code 532321
• NSE Code ZYDUSLIFE

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

MANAGEMENT

• Nitin Parekh Chief Financial Officer
• Tushar Shroff Chief Financial Officer
• Dhaval Soni Company Secretary, Compliance Officer
• Sharvil Patel Managing Director, Executive Director
• Ganesh Nayak Executive Director